Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
70%
Infectious Disease
62%
Infection
62%
Mustela Putorius Furo
58%
Immunogenicity
46%
Rhesus Monkey
35%
Vaccine Efficacy
28%
Neutralizing Antibody
25%
Booster Dose
23%
Spike
19%
Lung
18%
Neutralization
17%
Influenza A Virus (H3N2)
17%
Wild Type
17%
Influenza
16%
Viral Disease
16%
Interferon Gamma
15%
T Cell
14%
Virus Neutralization
14%
Antigen
14%
Virus
13%
Inactivated Vaccine
13%
Lymphocyte
13%
Low Drug Dose
12%
Commensal
11%
Influenza Virus
11%
Influenza Vaccine
11%
Intestine Flora
11%
Plague Vaccine
11%
Cross Protection
11%
Macaca fascicularis
11%
Binding Antibody
11%
Upper Respiratory Tract
10%
Nucleic Acid Amplification
10%
Antibody Response
10%
Immune Response
9%
Viral Shedding
9%
Bacteroides Thetaiotaomicron
9%
Plaque Reduction Neutralization Test
9%
Virus Particle
9%
Adoptive Immunity
7%
Influenza A Virus (H1N1)
7%
Lower Respiratory Tract
5%
Comorbidity
5%
Keyphrases
COVID-19
61%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
49%
Ferret
43%
ChAdOx1 nCoV-19
41%
Immunogenicity
35%
Rhesus Macaque
35%
BNT162b2
23%
Two-dose
23%
Third Dose
23%
Chad
23%
Reactogenicity
14%
Response to Infection
14%
Immunization
13%
Upper Respiratory Tract
13%
Ferret Model
13%
Lung Pathology
13%
MRNA-1273
12%
Prime-boost
11%
Randomized Trial
11%
Heterosubtypic
11%
Human Commensal
11%
Pathological Outcomes
11%
SARS-CoV-2 Challenge
11%
Plague
11%
Cynomolgus Macaque
11%
Microvesicles
11%
PIMS-TS
11%
Pediatric Inflammatory multisystem Syndrome Temporally Associated with SARS-CoV-2
11%
Platform Trials
11%
Fourth Dose
11%
Usual Care
11%
SARS-CoV-2 Neutralizing Antibodies
11%
Influenza Virus Infection
11%
Protective Immunity
11%
Non-inferiority Trial
11%
Phase II Trial
11%
Correlates of Protection
11%
Phase 2/3 Trial
11%
Control Phase
11%
Disease Model
11%
Asymptomatic SARS-CoV-2 Infection
11%
Challenge Model
11%
Immunomodulatory Therapy
11%
MRNA COVID-19 Vaccine
11%
Vectoring
11%
Formalin-inactivated Vaccine
11%
Binding Antibodies
11%
Vaccine Delivery
11%
Adenoviral
11%
Plague Vaccine
11%